PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
Ziekten en gezondheid in kaart brengen
Downloaden 843.4 KBPeer reviewed scientific article
Engels
SCIENSANO
Auteurs
J Thouvenin [2]; C Van Marcke [3]; L Decoster [4]; Gordana Raicevic [5]; K Punie [6]; Marc Van den Bulcke [7]; R Salgado [8]; Els Van Valckenborgh [9]; B Maes [10]; S Joris [11]; D Vander Steichel [12]; K Vranken [13]; S Jacobs [14]; F Dedeurwaerdere [15]; G Martens [16]; H Devos [17]; F P Duhoux [18]; M Rasschaert [19]; P Pauwels [20]; K Geboes [21]; J Collignon [22]; S Tejpar [23]; J-L Canon [24]; Michael Peeters [25]; A Rutten [26]; T Van de Mooter [27]; J Vermeij [28]; D Schrijvers [29]; W Demey [30]; W Lybaert [31]; J Van Huysse [32]; J Mebis [33]; A Awada [34]; K B M Claes [35]; Aline Hébrant [36]; J Van der Meulen [37]; B Delafontaine [38]; I Vanden Bempt [39]; J Maetens [40]; Maïté de Hemptinne [41]; S Rottey [42]; P Aftimos [43]; J De Grève [44]Trefwoorden
Article written during project(s) :
Samenvatting:
PRECISION is an initiative from the Belgian Society of Medical Oncology (BSMO) in collaboration with several stakeholders, encompassing four programs that aim to boost genomic and clinical knowledge with the ultimate goal to offer patients with metastatic solid tumors molecularly guided treatments. The PRECISION 1 study has led to the creation of a clinico-genomic database. The Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) and GeNeo studies will increase the number of patients with advanced cancer that have comprehensive genotyping of their cancer. The PRECISION 2 …